References
- Huang C, Wang Y, Xingwang L, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
- The great lockdown: worst economic downturn since the great depression – IMF Blog. [accessed 2021 May 20]. https://blogs.imf.org/2020/04/14/the-great-lockdown-worst-economic-downturn-since-the-great-depression/.
- WHO Coronavirus (COVID-19) dashboard | WHO Coronavirus (COVID-19) dashboard with vaccination data. [accessed 2021 March 26]. https://covid19.who.int/.
- Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382(21):1969–73. doi:10.1056/NEJMp2005630.
- Draft landscape and tracker of COVID-19 candidate vaccines. [accessed 2021 March 29]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
- Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. LANCET. 2021;397(10278):1023–34. doi:10.1016/S0140-6736(21)00306-8.
- COVID-19 vaccines. [accessed 2021 March 27]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.
- COVID-19 vaccination first phase priority groups - GOV.UK. [accessed 2021 May 27]. https://www.gov.uk/government/publications/covid-19-vaccination-care-home-and-healthcare-settings-posters/covid-19-vaccination-first-phase-priority-groups.
- ACIP COVID-19 Vaccine Recommendations | CDC. [accessed 2021 May 27]. https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html.
- Rosen B, Waitzberg R, Israeli A. Israel’s rapid rollout of vaccinations for COVID-19. ISR J HEALTH POLICY. 2021;10(1). doi:10.1186/s13584-021-00440-6.
- Press Conference of the Joint Prevention and Control Mechanism of the State Council on December. 2020 31 [accessed 2021 March 20]. http://www.gov.cn/xinwen/gwylflkjz143/index.htm.
- Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. NAT MED. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
- Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7):977–82. doi:10.1007/s10198-020-01208-6.
- Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. EUR J EPIDEMIOL. 2020;35(8):775–79. doi:10.1007/s10654-020-00671-y.
- Engineering And Medicine National Academies Of Sciences. Vaccine access and hesitancy: part one of a workshop series: proceedings of a workshop—in brief. Washington (DC): The National Academies Press; 2020. p. 5.
- Buttenheim AM. SARS-CoV-2 vaccine acceptance: we may need to choose our battles. ANN INTERN MED. 2020;173:1018–19. doi:10.7326/M20-6206.
- Chevallier C, Hacquin AS, Mercier H. COVID-19 vaccine hesitancy: shortening the last mile. TRENDS COGN SCI. 2021;25(5):331–33. doi:10.1016/j.tics.2021.02.
- Laine C, Cotton D, Moyer DV. COVID-19 vaccine: promoting vaccine acceptance. ANN INTERN MED. 2021;174(2):252–53. doi:10.7326/M20-8008.
- Dubé E, and MacDonald NE. Chapter 26 - vaccine acceptance: barriers, perceived risks, benefits, and irrational beliefs. In: Bloom BR, and Lambert P-H, editors. The vaccine book. 2nd ed. Cambridge, MA, USA: Academic Press;2016. p.507–528.
- Report of the Sage Working Group on Vaccine Hesitancy. [accessed 2021 March 2]. https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf.
- Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–59. doi:10.1016/j.vaccine.2014.01.081.
- Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine confidence gap. LANCET. 2011;378(9790):526–35. doi:10.1016/S0140-6736(11)60678-8.
- Kelly BJ, Southwell BG, McCormack LA, Bann CM, MacDonald PDM, Frasier AM, Bevc CA, Brewer NT, Squiers LB. Predictors of willingness to get a COVID-19 vaccine in the U.S. BMC Infect Dis. 2021;21(1). doi:10.1186/s12879-021-06023-9
- Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, Kriner DL. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Network Open. 2020;3(10):e2025594. doi:10.1001/jamanetworkopen.2020.255942020-10-20.
- Nguyen KH, Srivastav A, Razzaghi H, Williams W, Lindley MC, Jorgensen C, Abad N, Singleton JA. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination - United States, September and December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(6):217–22. doi:10.15585/mmwr.mm7006e3.
- Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–21. doi:10.1016/S2468-2667(21)00012-8.
- Lin C, Pikuei T, Beitsch LM. Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Vaccines. 2021;9(1):16. doi:10.3390/vaccines90100162020-12-30.
- Robinson E, Jones A, Lesser I, Michael D. International estimates of intended uptake and refusal of COVID-19 vaccines: a rapid systematic review and meta-analysis of large nationally representative samples. VACCINE. 2021;39(15):2024–34. doi:10.1016/j.vaccine.2021.02.005.
- Graffigna G, Palamenghi L, Boccia S, Barello S. Relationship between citizens’ health engagement and intention to take the COVID-19 vaccine in Italy: a mediation analysis. Vaccines. 2020;8(4):576. doi:10.3390/vaccines80405762020-10-01.
- Zhang Y, Luo X, Ma ZF. Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China. Hum Vaccin Immunother. 2021;17(6):1622–27. doi:10.1080/21645515.2020.1847585.
- Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 2020;8(3):482. doi:10.3390/vaccines80304822020-08-27.
- Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in southeast asia: a cross-sectional study in Indonesia. Front Public Health. 2020:8. doi:10.3389/fpubh.2020.003812020-07-14.
- Yoda T, Katsuyama H. Willingness to Receive COVID-19 Vaccination in Japan. Vaccines. 2021;9(1):48. doi:10.3390/vaccines90100482021-01-14.
- Chen S, Yang J, Yang W, Wang C, Barnighausen T. COVID-19 control in China during mass population movements at New Year. Lancet. 2020;395(10226):764–66. doi:10.1016/S0140-6736(20)30421-9.
- Burki T. China’s successful control of COVID-19. Lancet Infect Dis. 2020;20(11):1240–41. doi:10.1016/S1473-3099(20)30800-8.
- Wang J, Xinran L, Lai X, Lyu Y, Zhang H, Fenghuang Y, Jing R, Li L, Yu W, Fang H, et al. The changing acceptance of COVID-19 vaccination in different epidemic phases in China: Longitudinal study A. Vaccines. 2021;9(3):191. doi:10.3390/vaccines9030191.
- Lin Y, Zhijian H, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLOS NEGLECT TROP D. 2020;14(12):e8961. doi:10.1371/journal.pntd.00089612020-12-17.
- Press Conference of the Joint Prevention and Control Mechanism of the State Council on January. 2021 13 [accessed 2021 March 20]. http://www.gov.cn/xinwen/gwylflkjz145/index.htm.
- Baumgaertner B, Ridenhour BJ, Justwan F, Carlisle JE, Miller CR. Risk of disease and willingness to vaccinate in the United States: a population-based survey. PLoS Med. 2020;17(10):e1003354. doi:10.1371/journal.pmed.1003354.
- Lazarus JV, Wyka K, Rauh L, Rabin K, Ratzan S, Gostin LO, Larson HJ, El-Mohandes A. Hesitant or not? The association of age, gender, and education with potential acceptance of a COVID-19 vaccine: a country-level analysis. J Health Commun. 2020;25(10):799–807. doi:10.1080/10810730.2020.1868630.
- Verger P, Eve D. Restoring confidence in vaccines in the COVID-19 era. Expert Rev Vaccines. 2020;19(11):991–93. doi:10.1080/14760584.2020.1825945.
- Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16(11):2586–93. doi:10.1080/21645515.2020.1780846.
- Schiavo R. Vaccine communication in the age of COVID-19: getting ready for an information war. J Commun Healthc. 2020;13(2):73–75. doi:10.1080/17538068.2020.1778959.
- Coronavirus (COVID-19) vaccinations - statistics and research - our world in data. [accessed 2021 March 27]. https://ourworldindata.org/covid-vaccinations?country=OWID_WRL.
- Wu S, Yang P, Li H, Ma C, Zhang Y, Wang Q. Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional study. BMC Public Health. 2013;13:636. doi:10.1186/1471-2458-13-636.
- Brien S, Kwong JC, Buckeridge DL. The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review. Vaccine. 2012;30(7):1255–64. doi:10.1016/j.vaccine.2011.12.089.
- Chen M, Li Y, Chen J, Wen Z, Feng F, Zou H, Fu C, Chen L, Shu Y, Sun, C. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum Vaccin Immunother. 2021;1–10. doi:10.1080/21645515.2020.1853449.
- Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):2204–14. doi:10.1080/21645515.2020.1790279.
- Liu R, Zhang Y, Nicholas S, Leng A, Maitland E, Wang J. COVID-19 vaccination willingness among Chinese adults under the free vaccination policy. Vaccines. 2021;9(3):292. doi:10.3390/vaccines9030292.
- Tsai F, Yang H, Lin C, Liu JZ. Acceptability of COVID-19 vaccines and protective behavior among adults in Taiwan: associations between risk perception and willingness to vaccinate against COVID-19. INT J ENV RES PUB HE. 2021;18(11):5579. doi:10.3390/ijerph18115579.
- Murphy J, Vallieres F, Bentall RP, Shevlin M, McBride O, Hartman TK, McKay R, Bennett K, Mason L, Gibson-Miller J. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. NAT COMMUN. 2021;12(1):29. doi:10.1038/s41467-020-20226-9.
- Sethi S, Kumar A, Mandal A, Shaikh M, Hall CA, Kirk JMW, Moss P, Brookes MJ, Basu S. The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy. BMJ OPEN. 2021;11(6):e48856.
- Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, Ng RWY, Lai CKC, Boon SS, Lau JTF, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. VACCINE. 2021;39(7):1148–56. doi:10.1016/j.vaccine.2020.12.083.
- Alabdulla M, Reagu SM, Al Khal A, Elzain M, Jones RM. COVID‐19 vaccine hesitancy and attitudes in Qatar: a national cross‐sectional survey of a migrant‐majority population. Influenza Other Resp. 2021;15(3):361–70. doi:10.1111/irv.12847.
- Gan L, Chen Y, Hu P, Wu D, Zhu Y, Tan J, Li Y, Zhang D. Willingness to receive SARS-CoV-2 vaccination and associated factors among Chinese adults: a cross sectional survey. Int J Environ Res Public Health. 2021;18(4). doi:10.3390/ijerph18041993.
- Rui M, Suo L, Lu L, Pang X. Willingness of the general public to receive the COVID-19 vaccine during a second-level alert — Beijing municipality, China, May 2020. China CDC Weekly. 2021;3(25):531–37. doi:10.46234/ccdcw2021.118.
- These Countries Did Well With Covid. So Why Are They Slow on Vaccines? The New York Times. [accessed 2021 May 27]. https://www.nytimes.com/2021/04/17/world/asia/Japan-south-Korea-Australia-vaccines.html.
- Press Conference of the Joint Prevention and Control Mechanism of the State Council on March. 2020 28 [accessed 2021 Sept 21]. http://www.gov.cn/xinwen/gwylflkjz153/index.htm.
- Question and Answer for COVID-19 Vaccination. [accessed 2021 Spet 21]. http://www.gov.cn/xinwen/2021-04/01/content_5597357.htm.
- Mohamadi M, Lin Y, Vulliet MVS, Flahault A, Rozanova L, Fabre G. COVID-19 vaccination strategy in China: a case study. Epidemiologia. 2021;2(3):402–25. doi:10.3390/epidemiologia2030030.
- Press Conference of the Joint Prevention and Control Mechanism of the State Council on September. 2020 18 [accessed 2021 Spet 21]. http://www.gov.cn/xinwen/gwylflkjz153/index.htm.
- The 76th Press Conference on COVID-19 Prevention and Control in Zhejiang Province. [accessed 2021 Spet 21]. https://baijiahao.baidu.com/s?id=1708413801540021226&wfr=spider&for=pc.
- In Guangdong, 90% of people aged 12 and above were vaccinated against COVID-19. [accessed 2021 Spet 21]. https://m.gmw.cn/baijia/2021-09/08/1302561119.html.
- Press Conference of the Joint Prevention and Control Mechanism of the State Council on September. 2020 6 [accessed 2021 Spet 21]. http://www.gov.cn/xinwen/gwylflkjz153/index.htm.